Literature DB >> 8666160

Glycobiology of schistosomiasis.

R D Cummings1, A K Nyame.   

Abstract

Schistosomiasis is a helminthic parasitic disease that results in a wide-ranging pathology in the approximately 200 million infected people worldwide. Much of the immunity to the parasite is directed against carbohydrate determinants in both glycoproteins and glycolipids from the adult worms and their eggs. Circulating glycoproteins derived from the parasite may be diagnostic for the disease. Recent studies of the structures of schistosome-derived glycoconjugates reveal that they exhibit several interesting and novel motifs. Many schistosome glycans are rich in fucose and devoid of sialic acid. It is surprising that some of the fucosylated schistosome glycans contain the Lewis x (Le(x)) antigen that is also found on human leukocytes and other tissues. These Le(x)-containing glycans elicit autoantibodies, and the glycans may affect lymphocyte functions. This review highlights recent progress in schistosome research in terms of structure, function, and biosynthesis of glycoconjugates. It is hoped that the deeper understanding being gained about glycoconjugates will foster innovative new strategies for lessening the mortality and morbidity caused by these parasites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666160     DOI: 10.1096/fasebj.10.8.8666160

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  Modification of carbohydrate compositions of 31/36 kDa proteins of plerocercoids (sparganum) of Spirometra mansoni grown in different intermediate hosts.

Authors:  Hyun Jong Yang
Journal:  Korean J Parasitol       Date:  2004-06       Impact factor: 1.341

2.  Recognition of schistosome glycolipids by immunoglobulin E: possible role in immunity.

Authors:  D van Der Kleij; A G Tielens; M Yazdanbakhsh
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 3.  Marine glycobiology: current status and future perspectives.

Authors:  Gary S Caldwell; Helen E Pagett
Journal:  Mar Biotechnol (NY)       Date:  2010-06       Impact factor: 3.619

4.  Development and characterization of a specific IgG monoclonal antibody toward the Lewis x antigen using splenocytes of Schistosoma mansoni-infected mice.

Authors:  Msano Mandalasi; Nelum Dorabawila; David F Smith; Jamie Heimburg-Molinaro; Richard D Cummings; A Kwame Nyame
Journal:  Glycobiology       Date:  2013-03-29       Impact factor: 4.313

5.  Profiles of immunoglobulin M (IgM) and IgG antibodies against defined carbohydrate epitopes in sera of Schistosoma-infected individuals determined by surface plasmon resonance.

Authors:  A van Remoortere; G J van Dam; C H Hokke; D H van den Eijnden; I van Die; A M Deelder
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 6.  Carbohydrates as allergens.

Authors:  Scott P Commins
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

7.  Quantitative analysis of Northern bobwhite (Colinus virginianus) cytokines and TLR expression to eyeworm (Oxyspirura petrowi) and caecal worm (Aulonocephalus pennula) glycoproteins.

Authors:  Aravindan Kalyanasundaram; Kendall R Blanchard; Brett J Henry; Cassandra Henry; Matthew Z Brym; Ronald J Kendall
Journal:  Parasitol Res       Date:  2019-08-15       Impact factor: 2.289

Review 8.  Schistosome glycoconjugates in host-parasite interplay.

Authors:  C H Hokke; A M Deelder
Journal:  Glycoconj J       Date:  2001-08       Impact factor: 2.916

9.  The ruminant parasite Haemonchus contortus expresses an alpha1,3-fucosyltransferase capable of synthesizing the Lewis x and sialyl Lewis x antigens.

Authors:  R A DeBose-Boyd; A K Nyame; D P Jasmer; R D Cummings
Journal:  Glycoconj J       Date:  1998-08       Impact factor: 2.916

10.  Schistosoma mansoni α1,3-fucosyltransferase-F generates the Lewis X antigen.

Authors:  Megan L Mickum; Teerapat Rojsajjakul; Ying Yu; Richard D Cummings
Journal:  Glycobiology       Date:  2015-11-17       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.